Oslo, Norway

Gemvax As


USPTO Granted Patents = 10



Forward Citations = 206

Loading Chart...
Loading Chart...

13 inventors (with patents filed for the assignee):

goldMedal Jon Amund Eriksen (10 out of 17 patents)

silverMedal Gustav Gaudernack (9 out of 21 patents)

bronzeMedal Mona Møller (7 out of 7 patents)

4 Marianne Klemp Gjertsen (6 out of 6 patents)

5 Ingvil Sæterdal (3 out of 3 patents)

6 Mona Moller (2 out of 2 patents)

7 Ingvil Saeterdal (2 out of 2 patents)

8 Stein Sæbøe-Larssen (2 out of 2 patents)

9 Stein Sæbøe-Larsen (2 out of 2 patents)

10 Stein Sæøe-Larssen (1 out of 1 patent)

11 Gustay Gaudernack (1 out of 1 patent)

12 Mona Møller (1 out of 1 patent)

13 Ingvil Sæterdal (1 out of 1 patent)

14 Stein Saeboe-Larssen (0 patent)

15 Mona Moeller (0 patent)


10 patents:

Gemvax is a biopharmaceutical company dedicated to the development of innovative cancer therapies. With a focus on personalized medicine, Gemvax utilizes cutting-edge technologies to create targeted treatments that aim to improve patient outcomes. Through strategic partnerships and collaborations, Gemvax continues to advance the field of oncology and bring novel therapies to market.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

10 Patents

#52 in Oslo

#165 in Norway

#54,324 in the World

...
Oslo, Norway
Forward Citations = 206

13 inventors:

Please report any incorrect information to support@idiyas.com
Loading…